USCACA and NFCR recognize five young Chinese investigators with the 2014 USCACA-NFCR Scholar Awards

To facilitate and strengthen collaborations among cancer researchers and physicians in the United States and China, the US Chinese Anti-Cancer Association (USCACA) and the National Foundation for Cancer Research (NFCR) have established the Scholar Excellence Award for the USCACA-NFCR Scholar Exchange and Fellowship Program in Basic, Translational, and Clinical Studies.

USCACA Meeting Report: Breakthrough cancer medicine and its impact on novel drug development in China

The US Chinese Anti-Cancer Association (USCACA) teamed up with Chinese Society of Clinical
Oncology (CSCO) to host a joint session at the17th CSCO Annual Meeting on September 20th, 2014
in Xiamen, China. With a focus on breakthrough cancer medicines, the session featured innovative
approaches to evaluate breakthrough agents and established a platform to interactively share successful
experiences from case studies of 6 novel agents from both the United States and China. The goal of the

USCACA held its 6th Annual Meeting

The 6th Annual Meeting of the United States Chinese Anti-Cancer Association (USCACA) was held
in conjunction with the 50th Annual Meeting of American Society of Clinical Oncology (ASCO) on May
30, 2014 in Chicago, Illinois, the United States of America. With a focus on personalized medicine, the
conference featured novel approaches to investigate genomic aberrations in cancer cells and innovative
clinical trial designs to expedite cancer drug development in biomarker-defined patient populations. A panel

The Chinese Journal of Cancer is indexed in Science Citation Index (SCI) Expanded

On July 22, 2014, the Chinese Journal of Cancer (CJC) received a notification from Thomson Reuters that the publications of our journal starting from 2012 have been accepted for coverage in Science Citation Index Expanded, available as the Web of Science, Core Collection, Biological Abstracts, and Biosis Previews. What this means in practical terms is that CJC will receive its first official impact factor (IF) in 2015. This is an important milestone in the history of CJC.

Program of USCACA 2014 Annual Meeting

US Chinese Anti-Cancer Association Annual Meeting at ASCO 2014
6:30 - 9:00 pm
May 30, 2014
Hilton Chicago, Salon A-5, Lower Level
720 South Michigan Avenue, Chicago, 60605